FBT
DXCM icon

First Bank & Trust’s DexCom DXCM Stock Holding History

First Bank & Trust’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,778
Closed -$593K – 232
2023
Q4 		$593K Sell
4,778
-6,940
-59% -$709K 0.14% 99
2023
Q3 		$1.09M Buy
11,718
+585
+5% +$65.9K 0.29% 81
2023
Q2 		$1.43M Sell
11,133
-582
-5% -$70.4K 0.36% 68
2023
Q1 		$1.36M Buy
11,715
+274
+2% +$30.7K 0.36% 74
2022
Q4 		$1.3M Buy
11,441
+243
+2% +$26.7K 0.36% 69
2022
Q3 		$902K Buy
11,198
+410
+4% +$34.7K 0.33% 79
2022
Q2 		$804K Sell
10,788
-616
-5% -$56.2K 0.26% 84
2022
Q1 		$1.46M Buy
11,404
+812
+8% +$88.8K 0.45% 53
2021
Q4 		$1.42M Sell
10,592
-648
-6% -$93.1K 0.6% 46
2021
Q3 		$1.54M Buy
11,240
+108
+1% +$13.6K 0.7% 41
2021
Q2 		$1.19M Buy
11,132
+288
+3% +$27.7K 0.57% 55
2021
Q1 		$974K Buy
10,844
+2,464
+29% +$231K 0.49% 63
2020
Q4 		$775K Sell
8,380
-2,748
-25% -$245K 0.49% 62
2020
Q3 		$1.15M Sell
11,128
-536
-5% -$56K 0.76% 43
2020
Q2 		$1.18M Sell
11,664
-4,252
-27% -$380K 0.89% 37
2020
Q1 		$1.07M Buy
15,916
+492
+3% +$30.6K 0.96% 30
2019
Q4 		$843K Sell
15,424
-4,712
-23% -$223K 0.61% 52
2019
Q3 		$751K Buy
20,136
+1,444
+8% +$56.1K 0.57% 56
2019
Q2 		$700K Sell
18,692
-4,040
-18% -$127K 0.56% 62
2019
Q1 		$677K Sell
22,732
-1,120
-5% -$39.4K 0.53% 65
2018
Q4 		$714K Sell
23,852
-376
-2% -$11.9K 0.61% 54
2018
Q3 		$874K Hold
24,228
– – 0.66% 50
2018
Q2 		$575K Buy
24,228
+3,860
+19% +$81.8K 0.44% 69
2018
Q1 		$378K Sell
20,368
-1,832
-8% -$27.1K 0.3% 93
2017
Q4 		$318K Buy
22,200
+7,116
+47% +$92.5K 0.25% 102
2017
Q3 		$184K Buy
15,084
+308
+2% +$5.44K 0.15% 141
2017
Q2 		$270K Sell
14,776
-904
-6% -$16.7K 0.23% 105
2017
Q1 		$332K Sell
15,680
-7,164
-31% -$140K 0.29% 93
2016
Q4 		$341K Buy
+22,844
New +$405K 0.31% 88

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

First Bank & Trust's DXCM Position: Q1 2024 in Review

First Bank & Trust sold out of DexCom (DXCM) in Q1 2024, closing a stake of 4,778 shares — an estimated $593K sold.

First Bank & Trust first reported a position in DXCM in Q4 2016 and held it in 29 quarters. The position peaked at $1.54M in Q3 2021. 1,032 funds tracked by Wall St. Rank hold DXCM as of Q1 2024.

  • First Bank & Trust reported no remaining DexCom position as of Q1 2024 after selling out during the quarter.
  • First Bank & Trust sold 4,778 DexCom shares in Q1 2024, an estimated $593K.
  • First Bank & Trust first reported a position in DexCom in Q4 2016 and held it in 29 quarters.
  • First Bank & Trust's DexCom position peaked at $1.54M in Q3 2021.
  • 1,032 funds tracked by Wall St. Rank held DexCom as of Q1 2024.

Based on First Bank & Trust's 13F filing for Q1 2024, filed 17 Apr 2024.